pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    NTCDM-3
    Clostridioides difficile Infections (Clostridium difficil… Destiny Pharma Ltd
  • Phase 2
    NTM-006
    Post-Operative Pain Neumentum Inc
  • Phase 2
    NTX-1472
    Social Anxiety Disorder (SAD/Social Phobia) Newleos Therapeutics Inc
  • Phase 2
← prev
page 20 of 50
next →
131
Pain89
Neurology1
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
Pinotbio Inc
  • Phase 2
    NVG-291
    Chronic Spinal Cord Injury$NGEN NERVGEN PHARMA CORP.
  • Phase 2
    NVX-108
    perflenapent
    Glioblastoma Multiforme (GBM) NuvOx Pharma LLC
  • Phase 2
    NX-210c
    Amyotrophic Lateral Sclerosis Axoltis Pharma SAS
  • Phase 2
    NanoDOX
    NanoDOX
    Wounds Resilience Government Services Inc
  • Phase 2
    Nerofe
    Nerofe
    Refractory Acute Myeloid Leukemia Immune System Key Ltd
  • Phase 2
    Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
    Norovirus Infections$VXRT Vaxart, Inc.
  • Phase 2
    NouvNeu-001
    Parkinson's Disease iRegene Therapeutics Co Ltd
  • Phase 2
    Nov-DB2
    Obesity NovMetaPharma Co Ltd
  • Phase 2
    NovOB
    Obesity NovMetaPharma Co Ltd
  • Phase 2
    NovoCardia
    Congestive Heart Failure (Heart Failure) Help Therapeutics
  • Phase 2
    Nu-3
    Diabetic Foot Ulcers Lakewood-Amedex Inc
  • Phase 2
    NuGel
    Atopic Dermatitis (Atopic Eczema) Hudson Therapeutics Inc
  • Phase 2
    OA-SYS
    Osteoarthritis Ageless Biotech Inc
  • Phase 2
    OATD-01
    Pulmonary Sarcoidosis Molecure SA
  • Phase 2
    OBI-902
    Bile Duct Cancer (Cholangiocarcinoma) OBI Pharma Inc
  • Phase 2
    OBX-115
    Metastatic Melanoma Obsidian Therapeutics Inc
  • Phase 2
    OCU-410
    Geographic Atrophy$OCGN Ocugen, Inc.
  • Phase 2
    OLX-101A
    Hypertrophic Scars OliX Pharmaceuticals Inc
  • Phase 2
    OMO-1
    Solid Tumor DeuterOncology NV
  • Phase 2
    ONC-841
    Colorectal Cancer OncoC4 Inc
  • Phase 2
    ONO-2020
    Alzheimer's Disease Ono Pharmaceutical Co Ltd
  • Phase 2
    ONO-2808
    Multiple System Atrophy (Multi-System Degeneration) Ono Pharmaceutical Co Ltd
  • Phase 2
    OPC-1
    Acute Spinal Cord Injury$LCTX Lineage Cell Therapeutics, Inc.
  • Phase 2
    OPCT-001
    Retinal Degeneration BlueRock Therapeutics LP
  • Phase 2
    OPF-310
    Type 1 Diabetes (Juvenile Diabetes) Otsuka Pharmaceutical Co Ltd
  • Phase 2
    OPGx-BEST1
    Macular Degeneration$IRD Opus Genetics, Inc.